IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 256 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.42 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $177,405 | -7.2% | 38,990 | +43.6% | 0.00% | 0.0% |
| Q2 2023 | $191,206 | +112.0% | 27,160 | +84.0% | 0.00% | – |
| Q1 2023 | $90,190 | -4.4% | 14,761 | 0.0% | 0.00% | -100.0% |
| Q4 2022 | $94,323 | -33.1% | 14,761 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $141,000 | -13.5% | 14,761 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $163,000 | -46.4% | 14,761 | -19.1% | 0.00% | 0.0% |
| Q1 2022 | $304,000 | -17.8% | 18,247 | -6.0% | 0.00% | -50.0% |
| Q4 2021 | $370,000 | +13.8% | 19,408 | +47.1% | 0.00% | 0.0% |
| Q3 2021 | $325,000 | -5.2% | 13,191 | -0.0% | 0.00% | 0.0% |
| Q2 2021 | $343,000 | -17.5% | 13,197 | +0.5% | 0.00% | 0.0% |
| Q1 2021 | $416,000 | -35.4% | 13,136 | -5.4% | 0.00% | -50.0% |
| Q4 2020 | $644,000 | +63.5% | 13,883 | +16.1% | 0.00% | +33.3% |
| Q3 2020 | $394,000 | +30.9% | 11,959 | +9.1% | 0.00% | 0.0% |
| Q2 2020 | $301,000 | +8.3% | 10,957 | +18.0% | 0.00% | 0.0% |
| Q1 2020 | $278,000 | +26.4% | 9,285 | +16.7% | 0.00% | +50.0% |
| Q4 2019 | $220,000 | +30.2% | 7,953 | -14.6% | 0.00% | +100.0% |
| Q3 2019 | $169,000 | -25.9% | 9,313 | 0.0% | 0.00% | -50.0% |
| Q2 2019 | $228,000 | +88.4% | 9,313 | -26.8% | 0.00% | +100.0% |
| Q1 2019 | $121,000 | +7.1% | 12,718 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $113,000 | -28.0% | 12,718 | -8.6% | 0.00% | 0.0% |
| Q3 2018 | $157,000 | -11.8% | 13,918 | 0.0% | 0.00% | -50.0% |
| Q2 2018 | $178,000 | +22.8% | 13,918 | +61.8% | 0.00% | +100.0% |
| Q1 2018 | $145,000 | – | 8,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 12,201,261 | $203,150,000 | 4.07% |
| Paradigm Biocapital Advisors LP | 907,428 | $15,109,000 | 4.00% |
| Avoro Capital Advisors LLC | 9,125,000 | $151,931,000 | 2.77% |
| Logos Global Management LP | 1,000,000 | $16,650,000 | 2.16% |
| Avidity Partners Management LP | 6,043,219 | $100,620,000 | 2.10% |
| Orbimed Advisors | 6,633,006 | $110,440,000 | 1.79% |
| Parametrica Management Ltd | 134,679 | $2,240,000 | 1.66% |
| Boxer Capital, LLC | 1,935,133 | $32,220,000 | 1.66% |
| Fairmount Funds Management LLC | 389,588 | $6,487,000 | 1.53% |
| Long Focus Capital Management, LLC | 705,000 | $11,738,000 | 1.51% |